Skip to main content
Top
Published in: BMC Gastroenterology 1/2011

Open Access 01-12-2011 | Research article

Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of recurrent bleeding

Authors: Hsiu-Chi Cheng, Hsiao-Bai Yang, Wei-Lun Chang, Yi-Chun Yeh, Yu-Ching Tsai, Bor-Shyang Sheu

Published in: BMC Gastroenterology | Issue 1/2011

Login to get access

Abstract

Background

Serum response factor (SRF) is crucial for gastric ulcer healing process. The study determined if gastric ulcer tissues up-regulate SRF and if such up-regulation correlated with co-morbidities and the risk of recurrent bleeding.

Methods

Ulcer and non-ulcer tissues were obtained from 142 patients with active gastric ulcers for SRF expression assessed by immunohistochemistry. Based on the degree of SRF expression between these two tissue types, SRF up-regulation was classified as strong, intermediate, and weak patterns. The patients were followed-up to determine if SRF up-regulation correlated to recurrent bleeding.

Results

Gastric ulcer tissues had higher SRF expression than non-ulcer tissues (p < 0.05). Patients with strong SRF up-regulation had lower rates of stigmata of recent hemorrhage (SRH) on the ulcer base than the others (p < 0.05). Multivariate logistic regression confirmed that co-morbidities and weak SRF up-regulation were two independent factors of recurrent gastric ulcer bleeding (p < 0.05). Combining both factors, there was an 8.29-fold (95% CI, 1.31~52.62; p = 0.03) higher risk of recurrent gastric ulcer bleeding.

Conclusions

SRF expression is higher in gastric ulcer tissues than in non-ulcer tissues. Weak SRF up-regulation, combined with the presence of co-morbidities, increase the risk of the recurrent gastric ulcer bleeding.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rockall TA, Logan RFA, Devlin HB, Northfield TC: Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996, 38: 316-321. 10.1136/gut.38.3.316.CrossRefPubMedPubMedCentral Rockall TA, Logan RFA, Devlin HB, Northfield TC: Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996, 38: 316-321. 10.1136/gut.38.3.316.CrossRefPubMedPubMedCentral
2.
go back to reference Forrest JA, Finlayson ND, Sherman DJ: Endoscopy in gastrointestinal bleeding. Lancet. 1974, 2: 394-397. 10.1016/S0140-6736(74)91770-X.CrossRefPubMed Forrest JA, Finlayson ND, Sherman DJ: Endoscopy in gastrointestinal bleeding. Lancet. 1974, 2: 394-397. 10.1016/S0140-6736(74)91770-X.CrossRefPubMed
3.
go back to reference Yang CC, Shin JS, Lin XZ, Hsu PI, Chen KW, Lin CY: The natural history (fading time) of stigmata of recent hemorrhage in peptic ulcer disease. Gastrointest Endosc. 1994, 40: 562-566. 10.1016/S0016-5107(94)70253-5.CrossRefPubMed Yang CC, Shin JS, Lin XZ, Hsu PI, Chen KW, Lin CY: The natural history (fading time) of stigmata of recent hemorrhage in peptic ulcer disease. Gastrointest Endosc. 1994, 40: 562-566. 10.1016/S0016-5107(94)70253-5.CrossRefPubMed
4.
go back to reference Hung LC, Ching JY, Sung JJ, To KF, Hui AJ, Wong VW, Leong RW, Chan HL, Wu JC, Leung WK, Lee YT, Chung SC, Chan FK: Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology. 2005, 128: 1845-1850. 10.1053/j.gastro.2005.03.026.CrossRefPubMed Hung LC, Ching JY, Sung JJ, To KF, Hui AJ, Wong VW, Leong RW, Chan HL, Wu JC, Leung WK, Lee YT, Chung SC, Chan FK: Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology. 2005, 128: 1845-1850. 10.1053/j.gastro.2005.03.026.CrossRefPubMed
5.
go back to reference Wong GL, Wong VW, Chan Y, Ching JY, Au K, Hui AJ, Lai LH, Chow DK, Siu DK, Lui YN, Wu JC, To KF, Hung LC, Chan HL, Sung JJ, Chan FK: High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009, 137: 525-531. 10.1053/j.gastro.2009.05.006.CrossRefPubMed Wong GL, Wong VW, Chan Y, Ching JY, Au K, Hui AJ, Lai LH, Chow DK, Siu DK, Lui YN, Wu JC, To KF, Hung LC, Chan HL, Sung JJ, Chan FK: High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009, 137: 525-531. 10.1053/j.gastro.2009.05.006.CrossRefPubMed
6.
go back to reference Cheng HC, Chuang SA, Kao YH, Kao AW, Chuang CH, Sheu BS: Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepatogastroenterology. 2003, 50: 2270-2273.PubMed Cheng HC, Chuang SA, Kao YH, Kao AW, Chuang CH, Sheu BS: Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepatogastroenterology. 2003, 50: 2270-2273.PubMed
7.
go back to reference Tseng GY, Fang CT, Lin HJ, Yang HB, Tseng GC, Wang PC, Liao PC, Cheng YT, Huang CH: Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study. Aliment Pharmacol Ther. 2009, 30: 406-413. 10.1111/j.1365-2036.2009.04049.x.CrossRefPubMed Tseng GY, Fang CT, Lin HJ, Yang HB, Tseng GC, Wang PC, Liao PC, Cheng YT, Huang CH: Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study. Aliment Pharmacol Ther. 2009, 30: 406-413. 10.1111/j.1365-2036.2009.04049.x.CrossRefPubMed
8.
go back to reference Greenberg ME, Ziff EB: Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 1984, 311: 433-438. 10.1038/311433a0.CrossRefPubMed Greenberg ME, Ziff EB: Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 1984, 311: 433-438. 10.1038/311433a0.CrossRefPubMed
9.
go back to reference Treisman R: Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell. 1986, 46: 567-574. 10.1016/0092-8674(86)90882-2.CrossRefPubMed Treisman R: Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell. 1986, 46: 567-574. 10.1016/0092-8674(86)90882-2.CrossRefPubMed
10.
go back to reference Orr L: Scientists align billion-year-old protein with embryonic heart defects. 2004, Medical News Today Orr L: Scientists align billion-year-old protein with embryonic heart defects. 2004, Medical News Today
11.
go back to reference Chai J, Tarnawski A: Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing. J Physiol Pharmacol. 2002, 53: 147-157.PubMed Chai J, Tarnawski A: Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing. J Physiol Pharmacol. 2002, 53: 147-157.PubMed
12.
go back to reference Tarnawski A: Cellular mechanisms of gastric ulcer healing. The Stomach. Edited by: Domschke W, Konturek SJ. 1993, Berlin/New York: Springer-Verlag, 177-192.CrossRef Tarnawski A: Cellular mechanisms of gastric ulcer healing. The Stomach. Edited by: Domschke W, Konturek SJ. 1993, Berlin/New York: Springer-Verlag, 177-192.CrossRef
13.
go back to reference Tarnawski A: Molecular mechanisms of ulcer healing. Drug News Perspect. 2000, 13: 158-168. 10.1358/dnp.2000.13.3.858438.CrossRefPubMed Tarnawski A: Molecular mechanisms of ulcer healing. Drug News Perspect. 2000, 13: 158-168. 10.1358/dnp.2000.13.3.858438.CrossRefPubMed
14.
go back to reference Tarnawski A: Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci. 2005, 50: S24-33. 10.1007/s10620-005-2803-6.CrossRefPubMed Tarnawski A: Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci. 2005, 50: S24-33. 10.1007/s10620-005-2803-6.CrossRefPubMed
15.
go back to reference Chai J, Baatar D, Tarnawski A: Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing. Gastroenterology. 2004, 126: 1809-1818. 10.1053/j.gastro.2004.03.021.CrossRefPubMed Chai J, Baatar D, Tarnawski A: Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing. Gastroenterology. 2004, 126: 1809-1818. 10.1053/j.gastro.2004.03.021.CrossRefPubMed
16.
go back to reference Chai J, Norng M, Tarnawski A, Chow J: A critical role of serum response factor in myofibroblast differentiation during experimental oesophageal ulcer healing in rats. Gut. 2007, 56: 621-630. 10.1136/gut.2006.106674.CrossRefPubMed Chai J, Norng M, Tarnawski A, Chow J: A critical role of serum response factor in myofibroblast differentiation during experimental oesophageal ulcer healing in rats. Gut. 2007, 56: 621-630. 10.1136/gut.2006.106674.CrossRefPubMed
17.
go back to reference Sheu BS, Sheu SM, Yang HB, Huang AH, Wu JJ: Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Gut. 2003, 52: 927-932. 10.1136/gut.52.7.927.CrossRefPubMedPubMedCentral Sheu BS, Sheu SM, Yang HB, Huang AH, Wu JJ: Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Gut. 2003, 52: 927-932. 10.1136/gut.52.7.927.CrossRefPubMedPubMedCentral
18.
go back to reference Sheu BS, Cheng HC, Kao AW, Wang ST, Yang YY, Yang HB, Wu JJ: Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr. 2006, 83: 864-869.PubMed Sheu BS, Cheng HC, Kao AW, Wang ST, Yang YY, Yang HB, Wu JJ: Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr. 2006, 83: 864-869.PubMed
19.
go back to reference Sheu BS, Lin CY, Lin XZ, Shiesh SC, Yang HB, Chen CY: Long-term outcome of triple therapy in Helicobacter pylori-related non-ulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol. 1996, 91: 441-447.PubMed Sheu BS, Lin CY, Lin XZ, Shiesh SC, Yang HB, Chen CY: Long-term outcome of triple therapy in Helicobacter pylori-related non-ulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol. 1996, 91: 441-447.PubMed
20.
go back to reference Sung JJ, Mössner J, Barkun A, Kuipers EJ, Lau J, Jensen D, Stuart R, Junghard O, Olsson G: Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of peptic ulcer bleeding study. Aliment Pharmacol Ther. 2008, 27: 666-677. 10.1111/j.1365-2036.2008.03631.x.CrossRefPubMed Sung JJ, Mössner J, Barkun A, Kuipers EJ, Lau J, Jensen D, Stuart R, Junghard O, Olsson G: Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of peptic ulcer bleeding study. Aliment Pharmacol Ther. 2008, 27: 666-677. 10.1111/j.1365-2036.2008.03631.x.CrossRefPubMed
21.
go back to reference Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, Chan FK: Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol. 2000, 157: 729-735. 10.1016/S0002-9440(10)64586-5.CrossRefPubMedPubMedCentral Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, Chan FK: Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol. 2000, 157: 729-735. 10.1016/S0002-9440(10)64586-5.CrossRefPubMedPubMedCentral
22.
go back to reference Sheu BS, Yang HB, Sheu SM, Huang AH, Wu JJ: Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients. Clin Cancer Res. 2003, 9: 5245-5251.PubMed Sheu BS, Yang HB, Sheu SM, Huang AH, Wu JJ: Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients. Clin Cancer Res. 2003, 9: 5245-5251.PubMed
23.
go back to reference Chan HL, Wu JC, Chan FK, Choi CL, Ching JY, Lee YT, Leung WK, Lau JY, Chung SC, Sung JJ: Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest Endosc. 2001, 53: 438-442. 10.1067/mge.2001.112840.CrossRefPubMed Chan HL, Wu JC, Chan FK, Choi CL, Ching JY, Lee YT, Leung WK, Lau JY, Chung SC, Sung JJ: Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest Endosc. 2001, 53: 438-442. 10.1067/mge.2001.112840.CrossRefPubMed
24.
go back to reference Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY: Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?. Am J Gastroenterol. 1998, 93: 574-578. 10.1111/j.1572-0241.1998.167_b.x.CrossRefPubMed Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY: Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?. Am J Gastroenterol. 1998, 93: 574-578. 10.1111/j.1572-0241.1998.167_b.x.CrossRefPubMed
25.
go back to reference Schubert M, McGuire VAMC, Dewitt JM, Taylor CA: Prospective evaluation of the prevalence of H. pylori in duodenal and gastric ulcer: is its role overstated [abstract]?. Gastroenterology. 1999, 116: A305- Schubert M, McGuire VAMC, Dewitt JM, Taylor CA: Prospective evaluation of the prevalence of H. pylori in duodenal and gastric ulcer: is its role overstated [abstract]?. Gastroenterology. 1999, 116: A305-
26.
go back to reference Cheng HC, Kao AW, Chuang CH, Sheu BS: The efficacy of high and low dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Dig Dis Sci. 2005, 50: 1194-1201. 10.1007/s10620-005-2759-6.CrossRefPubMed Cheng HC, Kao AW, Chuang CH, Sheu BS: The efficacy of high and low dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Dig Dis Sci. 2005, 50: 1194-1201. 10.1007/s10620-005-2759-6.CrossRefPubMed
27.
go back to reference Martin P: Wound healing-aiming for perfect skin regeneration. Science. 1997, 276: 75-81. 10.1126/science.276.5309.75.CrossRefPubMed Martin P: Wound healing-aiming for perfect skin regeneration. Science. 1997, 276: 75-81. 10.1126/science.276.5309.75.CrossRefPubMed
28.
go back to reference Wang JY, Johnson LR: Expression of protooncogenes c-fos and c-myc in healing of gastric mucosal stress ulcers. Am J Physiol. 1994, 266: G878-G886.PubMed Wang JY, Johnson LR: Expression of protooncogenes c-fos and c-myc in healing of gastric mucosal stress ulcers. Am J Physiol. 1994, 266: G878-G886.PubMed
29.
go back to reference Mack CP, Thompson MM, Lawrenz-Smith S, Owens GK: Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ Res. 2000, 86: 221-232.CrossRefPubMed Mack CP, Thompson MM, Lawrenz-Smith S, Owens GK: Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ Res. 2000, 86: 221-232.CrossRefPubMed
30.
go back to reference Rensen SS, Niessen PM, Long X, Doevendans PA, Miano JM, van Eys GJ: Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins. Cardiovasc Res. 2006, 70: 136-145. 10.1016/j.cardiores.2005.12.018.CrossRefPubMed Rensen SS, Niessen PM, Long X, Doevendans PA, Miano JM, van Eys GJ: Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins. Cardiovasc Res. 2006, 70: 136-145. 10.1016/j.cardiores.2005.12.018.CrossRefPubMed
31.
go back to reference Chai J, Baatar D, Moon W, Tarnawski A: Expression of serum response factor in normal rat gastric mucosa. J Physiol Pharmacol. 2002, 53: 289-294.PubMed Chai J, Baatar D, Moon W, Tarnawski A: Expression of serum response factor in normal rat gastric mucosa. J Physiol Pharmacol. 2002, 53: 289-294.PubMed
32.
go back to reference Cheng HC, Chang WL, Yeh YC, Chen WY, Tsai YC, Sheu BS: Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities. Gastointest Endosc. 2009, 70: 433-439. 10.1016/j.gie.2009.01.041.CrossRef Cheng HC, Chang WL, Yeh YC, Chen WY, Tsai YC, Sheu BS: Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities. Gastointest Endosc. 2009, 70: 433-439. 10.1016/j.gie.2009.01.041.CrossRef
33.
go back to reference Zaragoza AM, Tenías JM, Llorente MJ, Alborch A: Prognostic factors in gastrointestinal bleeding due to peptic ulcer: construction of a predictive model. J Clin Gastroenterol. 2008, 42: 786-790. 10.1097/MCG.0b013e3180a5be63.CrossRefPubMed Zaragoza AM, Tenías JM, Llorente MJ, Alborch A: Prognostic factors in gastrointestinal bleeding due to peptic ulcer: construction of a predictive model. J Clin Gastroenterol. 2008, 42: 786-790. 10.1097/MCG.0b013e3180a5be63.CrossRefPubMed
34.
go back to reference Chai JY, Jones MK, Tarnawski A: Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis. FASEB J. 2004, 18: 1264-1266.PubMed Chai JY, Jones MK, Tarnawski A: Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis. FASEB J. 2004, 18: 1264-1266.PubMed
35.
go back to reference Johansen FE, Prywes R: Two pathways for serum regulation of the c-fos serum response element require specific sequence elements and a minimal domain of serum response factor. Mol Cell Biol. 1994, 14: 5920-5928.CrossRefPubMedPubMedCentral Johansen FE, Prywes R: Two pathways for serum regulation of the c-fos serum response element require specific sequence elements and a minimal domain of serum response factor. Mol Cell Biol. 1994, 14: 5920-5928.CrossRefPubMedPubMedCentral
36.
go back to reference Mitsuno Y, Maeda S, Yoshida H, Hirata Y, Ogura K, Akanuma M, Kawabe T, Shiratori Y, Omata M: Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation. Biochem Biophys Res Commun. 2002, 291: 868-874. 10.1006/bbrc.2002.6530.CrossRefPubMed Mitsuno Y, Maeda S, Yoshida H, Hirata Y, Ogura K, Akanuma M, Kawabe T, Shiratori Y, Omata M: Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation. Biochem Biophys Res Commun. 2002, 291: 868-874. 10.1006/bbrc.2002.6530.CrossRefPubMed
37.
go back to reference Hirata Y, Maeda S, Mitsuno Y, Tateishi K, Yanai A, Akanuma M, Yoshida H, Kawabe T, Shiratori Y, Omata M: Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology. 2002, 123: 1962-1971. 10.1053/gast.2002.37044.CrossRefPubMed Hirata Y, Maeda S, Mitsuno Y, Tateishi K, Yanai A, Akanuma M, Yoshida H, Kawabe T, Shiratori Y, Omata M: Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology. 2002, 123: 1962-1971. 10.1053/gast.2002.37044.CrossRefPubMed
38.
go back to reference Pan MR, Chang HC, Hung WC: Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases. Cell Signal. 2008, 20: 1134-1141. 10.1016/j.cellsig.2008.02.004.CrossRefPubMed Pan MR, Chang HC, Hung WC: Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases. Cell Signal. 2008, 20: 1134-1141. 10.1016/j.cellsig.2008.02.004.CrossRefPubMed
39.
go back to reference Suzuki H, Masaoka T, Minegishi Y, Motosugi Y, Miura S, Ishii H: Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44/p42 mitogen-activated protein kinase. Wound Rep Reg. 2004, 12: 93-99. 10.1111/j.1067-1927.2004.012116.x.CrossRef Suzuki H, Masaoka T, Minegishi Y, Motosugi Y, Miura S, Ishii H: Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44/p42 mitogen-activated protein kinase. Wound Rep Reg. 2004, 12: 93-99. 10.1111/j.1067-1927.2004.012116.x.CrossRef
40.
go back to reference Ng KM, Cho CH, Chang FY, Luo JC, Lin HC, Lin HY, Chi CW, Lee SD: Omeprazole promotes gastric epithelial cell migration. J Pharm Pharmacol. 2008, 60: 655-660. 10.1211/jpp.60.5.0012.CrossRefPubMed Ng KM, Cho CH, Chang FY, Luo JC, Lin HC, Lin HY, Chi CW, Lee SD: Omeprazole promotes gastric epithelial cell migration. J Pharm Pharmacol. 2008, 60: 655-660. 10.1211/jpp.60.5.0012.CrossRefPubMed
41.
go back to reference Handa O, Yoshida N, Fujita N, Tanaka Y, Ueda M, Takagi T, Kokura S, Naito Y, Okanoue T, Yoshikawa T: Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm Res. 2006, 55: 476-480. 10.1007/s00011-006-6056-4.CrossRefPubMed Handa O, Yoshida N, Fujita N, Tanaka Y, Ueda M, Takagi T, Kokura S, Naito Y, Okanoue T, Yoshikawa T: Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm Res. 2006, 55: 476-480. 10.1007/s00011-006-6056-4.CrossRefPubMed
42.
go back to reference Gilinsky NH: Peptic ulcer disease in the elderly. Scand J Gastroenterol. 1988, 23 (Suppl 146): 191-200. 10.3109/00365528809099146.CrossRef Gilinsky NH: Peptic ulcer disease in the elderly. Scand J Gastroenterol. 1988, 23 (Suppl 146): 191-200. 10.3109/00365528809099146.CrossRef
43.
go back to reference Branicki FJ, Coleman SY, Fok PJ, Pritchett CJ, Fan ST, Lai EC, Mok FP, Cheung WL, Lau PW, Tuen HH, Lam SK, Hui WM, Ng MM, Lam DK, Tse MC, Tang AP, Wong J: Bleeding peptic ulcer: A prospective evaluation of risk factors for rebleeding and mortality. World J Surg. 1990, 14: 262-269. 10.1007/BF01664889.CrossRefPubMed Branicki FJ, Coleman SY, Fok PJ, Pritchett CJ, Fan ST, Lai EC, Mok FP, Cheung WL, Lau PW, Tuen HH, Lam SK, Hui WM, Ng MM, Lam DK, Tse MC, Tang AP, Wong J: Bleeding peptic ulcer: A prospective evaluation of risk factors for rebleeding and mortality. World J Surg. 1990, 14: 262-269. 10.1007/BF01664889.CrossRefPubMed
44.
go back to reference Cook DJ, Guyatt GH, Salena BJ, Laine LA: Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis. Gastroenterology. 1992, 102: 139-148.CrossRefPubMed Cook DJ, Guyatt GH, Salena BJ, Laine LA: Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis. Gastroenterology. 1992, 102: 139-148.CrossRefPubMed
Metadata
Title
Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of recurrent bleeding
Authors
Hsiu-Chi Cheng
Hsiao-Bai Yang
Wei-Lun Chang
Yi-Chun Yeh
Yu-Ching Tsai
Bor-Shyang Sheu
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2011
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-11-24

Other articles of this Issue 1/2011

BMC Gastroenterology 1/2011 Go to the issue